• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

The task of developing ESC Guidelines covers not only the integration of the most recent
research, but also the creation of educational tools and implementation programmes for the …

RH4W it has been shown that the outcome of disease may be favourably influenced by the
thorough application of clinical recommendations. Surveys and registries are needed to …

Aims Cardiomyopathies are a heterogeneous group of disorders associated with premature
death due to ventricular arrhythmia or heart failure. The purpose of this study was to …

Abstract Aims The Cardiomyopathy Registry of the EURObservational Research Programme
is a prospective, observational, and multinational registry of consecutive patients with four …

Abstract Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator)(Netherlands),
P. Christian Schulze (CPG Review Coordinator)(Germany), Magdy Abdelhamid (Egypt) …

Heart failure is a clinical syndrome that normally requires health care to be provided by both
specialists and nonspecialists. This is advantageous because patients benefit from …

4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

The aim of this ESC Guideline is to help health professionals manage people with heart
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …